Qingjing Zhu

机构：First Affiliated Hospital Zhejiang University · ORCID：0000-0002-8947-8881

发表论文 35 篇 · 总被引 622 次 · h-index 12

代表论文

• Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease (2017 · British Journal of Pharmacology · 被引 203)
• Creg in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1‐Dependent Manner in Mice (2018 · Hepatology · 被引 75)
• [Novel coronavirus pneumonia-related liver injury: etiological analysis and treatment strategy]. (2020 · PubMed · 被引 72)
• TAK1: A Molecular Link Between Liver Inflammation, Fibrosis, Steatosis, and Carcinogenesis (2021 · Frontiers in Cell and Developmental Biology · 被引 45)
• Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications (2023 · Frontiers in Nutrition · 被引 41)
• Clinical and Laboratory Factors Predicting the Prognosis of Patients with COVID-19: An Analysis of 127 Patients in Wuhan, China (2020 · SSRN Electronic Journal · 被引 40)